Search
for
Sort by
Research 421–450 of 1000+
- Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil
- Eclipta prostrata (L.) L.: Traditional Use, Phytochemistry, and Pharmacology
- GC-MS analysis of rhizome ethanol extracts from Curcuma aeruginosa accessions and their efficiency activities as anticancer agent
- Infections, Infestations and Neoplasms of the Scalp
- Hair loss in the era of CGRP inhibition: emerging evidence, mechanisms, and clinical implications
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Delphi Consensus on Attenuated Androgen Use for Long‐Term Prophylaxis in Hereditary Angioedema: AURA Project
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- Fatal Case of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Induced by Doxycycline or Flucloxacillin in a 77-Year-Old Woman: A Rare but Serious Adverse Drug Reaction
- Gray Hair: From Preventive to Treatment
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- Drug‐Induced Liver Failure Following Topical Minoxidil: A Case Report
- The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
- Valproate-induced thrombocytopenia
- A review on polyherbal and supplemental approach to treat Polycystic Ovarian Syndrome
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Blue-gray discoloration of the skin after levofloxacin exposure in a 44-year-old man with pulmonary tuberculosis
- Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: A pilot, randomized open-label study
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Association of Acne Tarda with Endocrinological Disorders
- 1,314
- Novel Formula as Mosquito Larvicide
- Advances in Knowledge of Androgens: How Intentional and Accidental Neurosteroid Changes Inform Us of Their Action and Role
- Distinctive Acne Entities
- Oral Presentations
- Neurosteroids on the Epilepsy Chessboard—Keeping Seizures in Check
- 25-Year-Old Woman With New-Onset Seizures
- Vitmain D level in female pattern hair loss with normal androgen level